The BRACELET Study: surveys of mortality in UK neonatal and paediatric intensive care trials

Claire Snowdon1, Sheila E Harvey, Peter Brocklehurst

  • 1Medical Statistics Unit, London School of Hygiene and Tropical Medicine, London, UK.

Trials
|May 28, 2010
PubMed

Insights

Deaths in pediatric and neonatal intensive care trials are common, yet few trials have bereavement support policies. This study highlights the need for developing and assessing bereavement care strategies in clinical trials.

Area of Science:

  • Pediatric Intensive Care
  • Neonatal Intensive Care
  • Clinical Trials
  • Bereavement Studies

Background:

  • Research on death and bereavement in pediatric and neonatal intensive care randomized controlled trials (RCTs) is limited.
  • The Bereavement and RAndomised ControlLEd Trials (BRACELET) Study aimed to assess trial activity, mortality, and bereavement support policies in UK NICUs and PICUs between 2002-2006.
  • Understanding these factors is crucial for developing future policies and practices for bereavement support following a child's trial enrollment.

Purpose of the Study:

  • To determine the extent of trial activity in UK neonatal and paediatric intensive care units from 2002 to 2006.
  • To quantify the number of deaths occurring before hospital discharge among participants in these trials.
  • To examine variations in mortality rates across different intensive care units and trials, and to assess the availability of bereavement support policies within trials.

Main Methods:

  • A survey of neonatal units (level 2 or 3 care) and paediatric units (level II care or above) in the UK.
  • A survey of randomized controlled trials involving intensive care patients or parents, with interventions designed to affect patient outcomes.
  • Data collection on trial participation, patient enrollment, mortality, and existing bereavement support policies.

Main Results:

  • Information was gathered from 191 neonatal and 28 paediatric units, with 90 units participating in at least one trial.
  • Fifty trials were identified, enrolling 3,137 infants in neonatal trials and 210 children in paediatric trials.
  • A total of 534 participants (16%) died post-enrollment (522 in neonatal, 12 in paediatric trials); only three trials reported a formal bereavement policy.

Conclusions:

  • A significant number of deaths occurred among participants enrolled in neonatal and paediatric intensive care trials.
  • Bereavement support policies were largely absent within the studied trials.
  • Units and trials with higher mortality rates may be best positioned to lead the development and evaluation of bereavement support strategies.
Abstract

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...